{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:31:17Z","timestamp":1759825877679},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin intervent Radiol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uterine fibroids are the most common benign neoplasm of the female pelvis and have a lifetime prevalence exceeding 80% among African American women and approaching 70% among Caucasian women. Approximately 50% of women with fibroids experience symptoms which can range from heavy menstrual bleeding and bulk-related symptoms such as pelvic pressure with bladder and bowel dysfunction to reproductive dysfunction (e.g., infertility or obstetric complications) and pain. The choice of treatment is primarily guided by the type of symptoms in the individual patient and whether they prefer to retain fertility. While hysterectomy provides definitive resolution of fibroid symptoms and remains the most common treatment option, this procedure is invasive with a long recovery window. Radiofrequency ablation (RFA) is now emerging as a uterine preserving and minimally invasive therapy for symptomatic fibroids. Since its introduction, growing evidence for safety and efficacy of RFA has been generated with low rates of complications. This review will discuss RFA for the management of symptomatic uterine fibroids with a special focus on technical approaches, short- and long-term outcomes including fertility outcomes.<\/jats:p>","DOI":"10.1055\/s-0043-1770734","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T22:41:07Z","timestamp":1691707267000},"page":"335-341","source":"Crossref","is-referenced-by-count":4,"title":["Updates on the Surgical Approach to Fibroids: The Importance of Radiofrequency Ablation"],"prefix":"10.1055","volume":"40","author":[{"given":"Caroline S.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor Dasouki","family":"Abu-Alnadi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"D D Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"08","key":"ref2","doi-asserted-by":"publisher","DOI":"10.12788\/obgm.0024","article-title":"New hormonal medical treatment is an important advance for AUB caused by uterine fibroids","volume":"32","author":"R L Barbieri","year":"2020","journal-title":"OBGM"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/AOG.0000000000005053","article-title":"Use of conservative therapies before hysterectomy for uterine leiomyomas","volume":"141","author":"L Liao","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"B J Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","volume-title":"Uterine fibroids (leiomyomas): abdominal myomectomy","author":"W H Parker"},{"key":"ref6","volume-title":"Overview of hysteroscopy","author":"L D Bradley"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1914735","article-title":"Uterine-artery embolization or myomectomy for uterine fibroids","volume":"383","author":"I Manyonda","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/BRS.0b013e31817329f0","article-title":"Percutaneous lumbar zygapophysial (Facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: a randomized double-blind trial","volume":"33","author":"S Nath","year":"2008","journal-title":"Spine"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.294.18.2323","article-title":"Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial","volume":"294","author":"G Doukas","year":"2005","journal-title":"JAMA"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-008-9941-y","article-title":"Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series","volume":"15","author":"Y S Kim","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.ju.0000165655.91152.c5","article-title":"Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup","volume":"174","author":"I M Varkarakis","year":"2005","journal-title":"J Urol"},{"key":"ref12","first-page":"9S","article-title":"Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative","volume":"99","author":"B B Lee","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref13","first-page":"362","volume-title":"Tissue ablation","author":"D Hammerich","year":"2006"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.jvir.2010.04.008","article-title":"Radiofrequency ablation: mechanism of action and devices","volume":"21","author":"K Hong","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1076-6332(96)80443-0","article-title":"Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size","volume":"3","author":"S N Goldberg","year":"1996","journal-title":"Acad Radiol"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jmig.2019.07.025","article-title":"Laparoscopic radiofrequency ablation of uterine leiomyomas: clinical outcomes during early adoption into surgical practice","volume":"27","author":"V L Jacoby","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/uog.11118","article-title":"Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity","volume":"40","author":"H Iversen","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jmig.2022.01.009","article-title":"Clinical and patient reported outcomes of pre- and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy","volume":"29","author":"S Yu","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/AOG.0000000000003032","article-title":"Ultrasound-guided transcervical ablation of uterine leiomyomas","volume":"133","author":"S Chudnoff","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jmig.2022.06.006","article-title":"Postoperative uterine necrosis and peritonitis following laparoscopic radiofrequency myoma ablation","volume":"29","author":"E Lin","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/lap.2019.0550","article-title":"Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies","volume":"29","author":"L D Bradley","year":"2019","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"05","key":"ref25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","article-title":"Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"J M Berman","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmig.2018.09.772","article-title":"Quality of life, adverse events, and reintervention outcomes after laparoscopic radiofrequency ablation for symptomatic uterine fibroids: a meta-analysis","volume":"26","author":"L Lin","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1089\/jwh.2017.6752","article-title":"Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids","volume":"27","author":"M R Davis","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e31828b7962","article-title":"Outpatient procedure for the treatment and relief of symptomatic uterine myomas","volume":"121","author":"S G Chudnoff","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJWH.S201912","article-title":"12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids","volume":"11","author":"J Hudgens","year":"2019","journal-title":"Int J Womens Health"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"H Br\u00f6lmann","year":"2016","journal-title":"Gynecol Surg"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/gyn.2018.0051","article-title":"Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY Study","volume":"35","author":"J G Garza-Leal","year":"2019","journal-title":"J Gynecol Surg"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/gyn.2020.0021","article-title":"Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata","volume":"36","author":"A Lukes","year":"2020","journal-title":"J Gynecol Surg"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jmig.2017.07.007","article-title":"Minimally invasive approaches to myoma management","volume":"25","author":"J A Gingold","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijgo.2013.11.012","article-title":"Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy","volume":"125","author":"S Y Brucker","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-0035-1545931","article-title":"Radiofrequency volumetric thermal ablation of fibroids and laparoscopic myomectomy: long-term follow-up from a randomized trial","volume":"75","author":"M Hahn","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CEOR.S253891","article-title":"The CHOICES Study: facility level comparative cost, resource utilization, and outcomes analysis of myomectomy compared to transcervical fibroid ablation","volume":"12","author":"E A Brooks","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"E R Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jmig.2019.06.009","article-title":"Case series of reproductive outcomes after laparoscopic radiofrequency ablation of symptomatic myomas","volume":"27","author":"J M Berman","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10397-014-0842-8","article-title":"The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis","volume":"11","author":"J Claeys","year":"2014","journal-title":"Gynecol Surg"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/gyn.2021.0136","article-title":"Pregnancy outcomes after transcervical radiofrequency ablation of uterine fibroids with the Sonata system","volume":"38","author":"L Christoffel","year":"2022","journal-title":"J Gynecol Surg"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/gyn.2019.0033","article-title":"The INTEGRITY Trial: preservation of uterine-wall integrity 12 months after transcervical fibroid ablation with the Sonata system","volume":"35","author":"M Bongers","year":"2019","journal-title":"J Gynecol Surg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejogrb.2019.09.013","article-title":"Evaluation of uterine patency following transcervical uterine fibroid ablation with the Sonata system (the OPEN clinical trial)","volume":"242","author":"M Bongers","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1074-3804(05)60478-1","article-title":"Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery","volume":"7","author":"O Taskin","year":"2000","journal-title":"J Am Assoc Gynecol Laparosc"}],"container-title":["Seminars in Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1770734.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T23:18:11Z","timestamp":1695683891000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1770734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,8,10]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1770734","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0739-9529","1098-8963"],"issn-type":[{"value":"0739-9529","type":"print"},{"value":"1098-8963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}